Photobiomodulation Can Prevent Medication-Related Osteonecrosis of the Jaw Formation in Tooth Extraction Site of Rat Model

被引:1
作者
Chegini, Leila [1 ]
Bastami, Farshid [2 ]
Mashhadi-Abbas, Fatemeh [3 ]
Chegini, Reihane [4 ]
Hadadi-Ahangarkolaee, Zahra [1 ]
Fekrazad, Reza [5 ,6 ,7 ]
Dehaki, Mehrzad Gholampour [7 ]
机构
[1] AJA Univ Med Sci, Sch Med, Internal Med Dept, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Res Inst Dent Sci, Dent Res Ctr, Sch Dent,Oral & Maxillofacial Surg Dept, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Sch Dent, Oral & Maxillofacial Pathol Dept, Tehran, Iran
[4] Iran Univ Med Sci, Sch Med, Med Pathol Dept, Tehran, Iran
[5] AJA Univ Med Sci, Radiat Sci Res Ctr, Tehran, Iran
[6] Universal Sci Educ & Res Network USERN, Int Network Photo Med & Photo Dynam Therapy INPMPD, Tehran, Iran
[7] AJA Univ Med Sci, Sch Med, Endocrinol Dept, Tehran 1946883893, Iran
关键词
photobiomodulation; medication-related osteonecrosis of the jaw; MRONJ; zoledronic acid; rat model; wound healing; BISPHOSPHONATE-RELATED OSTEONECROSIS; LEVEL LASER THERAPY; HUMAN GINGIVAL FIBROBLASTS; ZOLEDRONIC ACID; IN-VITRO; SURGICAL-TREATMENT; CANCER-PATIENTS; RISK-FACTORS; OSTEOBLASTS; CELLS;
D O I
10.1089/photob.2023.0135
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: This study aims to explore the preventive potential of photobiomodulation (PBM) in bisphosphonate-related osteonecrosis of the jaw (BRONJ) using a rat model.Methods: An experimental rat model was established, exposing rats to zoledronic acid (ZA), a primary risk factor for BRONJ. An 810 nm diode laser was applied with parameters of 0.33 W/cm2 power density and 10 J/cm2 energy density for 30 sec. PBM was initiated 1 day pre-extraction and continued for 2 weeks. The impact of PBM on wound healing in both soft and hard tissues was evaluated post tooth extraction.Results: ZA exposure hindered wound healing in both soft and hard tissues after tooth extraction. PBM intervention effectively mitigated the adverse effects of ZA, promoting healing processes in both tissue types. This suggests the potential of PBM as a preventive strategy for BRONJ in patients on long-term bisphosphonate treatment. Moreover, PBM exhibited enhanced wound healing in normal rats, indicating its broader applicability beyond BRONJ cases.Conclusions: PBM shows promise in preventing and improving wound healing in BRONJ and normal cases. These findings underscore the significance of optimizing PBM parameters and suggest its potential clinical relevance as a preventive intervention for BRONJ and a promoter of wound healing.
引用
收藏
页码:285 / 293
页数:9
相关论文
共 69 条
  • [31] Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review
    Lopez-Jornet, Pia
    Sanchez Perez, Arturo
    Mendes, Rui Amaral
    Tobias, Aurelio
    [J]. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2016, 44 (08) : 1067 - 1072
  • [32] Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis
    Manfredi, M.
    Merigo, E.
    Guidotti, R.
    Meleti, M.
    Vescovi, P.
    [J]. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2011, 40 (03) : 277 - 284
  • [34] Risk factors for medication-related osteonecrosis of the jaws: A systematic review
    McGowan, K.
    McGowan, T.
    Ivanovski, S.
    [J]. ORAL DISEASES, 2018, 24 (04) : 527 - 536
  • [35] Laser surgery in management of medication-related osteonecrosis of the jaws: a meta-analysis
    Momesso, Gustavo Antonio Correa
    Lemos, Cleidiel Aparecido Araujo
    Santiago-Junior, Joel Ferreira
    Faverani, Leonardo Perez
    Pellizzer, Eduardo Piza
    [J]. ORAL AND MAXILLOFACIAL SURGERY-HEIDELBERG, 2020, 24 (02): : 133 - 144
  • [36] Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis
    Morita, Mayu
    Iwasaki, Ryotaro
    Sato, Yuiko
    Kobayashi, Tami
    Watanabe, Ryuichi
    Oike, Takatsugu
    Nakamura, Satoshi
    Keneko, Yosuke
    Miyamoto, Kana
    Ishihara, Kazuyuki
    Iwakura, Yoichiro
    Ishii, Ken
    Matsumoto, Morio
    Nakamura, Masaya
    Kawana, Hiromasa
    Nakagawa, Taneaki
    Miyamoto, Takeshi
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [37] Effects of low-level laser therapy on the proliferation and apoptosis of gingival fibroblasts treated with zoledronic acid
    Nogueira Pansani, T.
    Goncalves Basso, F.
    Silveira Turirioni, A. P.
    Kurachi, C.
    Hebling, J.
    de Souza Costa, C. A.
    [J]. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2014, 43 (08) : 1030 - 1034
  • [38] Zoledronic acid induces S-phase arrest via a DNA damage response in normal human oral keratinocytes
    Ohnuki, Hisashi
    Izumi, Kenji
    Terada, Michiko
    Saito, Taro
    Kato, Hiroko
    Suzuki, Akiko
    Kawano, Yoshiro
    Nozawa-Inoue, Kayoko
    Takagi, Ritsuo
    Maeda, Takeyasu
    [J]. ARCHIVES OF ORAL BIOLOGY, 2012, 57 (07) : 906 - 917
  • [39] Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches
    On, Sung-Woon
    Cho, Seoung-Won
    Byun, Soo-Hwan
    Yang, Byoung-Eun
    [J]. ANTIOXIDANTS, 2021, 10 (05)
  • [40] Bisphosphonate-related osteonecrosis of the jaws - Characteristics, risk factors, clinical features, localization and impact on oncological treatment
    Otto, Sven
    Schreyer, Christian
    Hafner, Sigurd
    Mast, Gerson
    Ehrenfeld, Michael
    Stuerzenbaum, Stephen
    Pautke, Christoph
    [J]. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2012, 40 (04) : 303 - 309